COMMUNIQUÉS West-GlobeNewswire

Financière de Tubize SA: Convocation de l'assemblée générale ordinaire et de l'assemblée générale extraordinaire des actionnaires du 25 avril 2018
21/03/2018
Financière de Tubize SA Allée de la Recherche 60 1070 Bruxelles BE 0403.216.429 www.financiere-tubize.be CONVOCATION DE L'ASSEMBLEE GENERALE ORDINAIRE DES ACTIONNAIRES ET DE L'ASSEMBLEE GENERALE EXTRAORDINAIRE DU 25 [...]
MHRA Grants UK Patients Early Access to Akcea Therapeutics’ Volanesorsen for Familial Chylomicronaemia Syndrome (FCS)
21/03/2018
LONDON, March 21, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics United Kingdom (UK) Ltd today announced that volanesorsen has been granted a positive scientific opinion through the Early Access to Medicines Scheme (EAMS) [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
21/03/2018
REGULATED INFORMATION GHENT, Belgium, 21 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Bone Therapeutics SA : Information on the total number of voting rights and shares
21/03/2018
Regulated information Information on the total number of voting rights and shares Gosselies, Belgium, 21 March 2018, 7am CET - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d'actions
21/03/2018
Information réglementée Information relative au nombre total de droits de vote et d'actions Gosselies, Belgique, le 21 mars 2018, 7h00 CET - BONE THERAPEUTICS (code Euronext Bruxelles et Paris: BOTHE), société de [...]
Sorrento Therapeutics CEO Dr Ji to Present at Needham 17th Annual Healthcare Conference on 03/27/18
21/03/2018
SAN DIEGO, March 20, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that Dr Ji will present at the Needham 17 th Annual Healthcare Conference in NYC on March 27 th [...]
XORTX Announces Issuance of Stock Options
21/03/2018
CALGARY, Alberta, March 20, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney [...]
scPharmaceuticals Inc. Reports Fourth Quarter 2017 Financial Results
21/03/2018
Announced $147.7 Million of equity capital raising in 2017; Completed an Initial Public Offering; Advances towards FUROSCIX™ PDUFA date BURLINGTON, Mass., March 20, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. ( [...]
DiaMedica Therapeutics Announces Closing of Private Placement
20/03/2018
MINNEAPOLIS, March 20, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX-V: DMA ) (OTCQB:DMCAF) is pleased to announce the successful completion of the first closing of a private placement for [...]
Immunovaccine Announces Year-End 2017 Financial Results
20/03/2018
HALIFAX, Nova Scotia, March 20, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology corporation, today released its financial and operational results for the fiscal [...]
DBV Technologies Annonce le lancement d'une offre globale d'actions ordinaires, pouvant prendre la forme d'American Depositary Shares
20/03/2018
Montrouge, France, le 20 mars 2018, 21h00 CET DBV Technologies Annonce le lancement d'une offre globale d'actions ordinaires, pouvant prendre la forme d'American Depositary Shares DBV Technologies (la « Société ») ( [...]
Galapagos increases share capital through warrant exercises
20/03/2018
Mechelen, Belgium; 20 March 2018, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 298,184 new ordinary [...]
R1 RCM to Begin Trading on the Nasdaq Global Market
20/03/2018
CHICAGO, March 20, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1” or the “Company”) (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced it has [...]
Orion Biotechnology Canada Announces Closing of $5 Million Financing
20/03/2018
OTTAWA, March 20, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd today announced it has completed a US$5 million private placement financing late last year. “We are delighted to have secured the financial [...]
Emblem Corp. Issues President’s Letter to Shareholders
20/03/2018
TORONTO, March 20, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (" Emblem " or the " Corporation ") provides a Letter to its Shareholders as follows: Spring is upon us, and Emblem is ready to bloom. Having [...]
Strongbridge Biopharma Announces Issuance of Patent for RECORLEV™ (levoketoconazole) for the Treatment of Cushing’s Syndrome
20/03/2018
DUBLIN, Ireland and TREVOSE, Pa., March 20, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases
20/03/2018
Prothena to receive a $100 million upfront payment and a $50 million equity investment by Celgene, with potential license payments and regulatory and commercial milestones, plus additional royalties on net sales from [...]
Alder BioPharmaceuticals® Appoints Paul B. Cleveland as Interim President and Chief Executive Officer
20/03/2018
BOTHELL, Wash., March 20, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares
20/03/2018
Montrouge, France, March 20, 2018, 9:00 p.m., CET DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares DBV Technologies (the " [...]

Pages